Stay updated on Talazoparib in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.
Clouds background image

Latest updates to the Talazoparib in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    68 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.1%
    Check dated 2025-01-08T12:47:18.000Z thumbnail image
  2. Check
    90 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.0%
    Check dated 2024-12-17T16:38:03.000Z thumbnail image
  3. Check
    97 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.
    Difference
    0.8%
    Check dated 2024-12-10T13:24:32.000Z thumbnail image
  4. Check
    112 days ago
    Change Detected
    Summary
    Several key URLs related to genetics, clinical trials, and medical resources have been removed, indicating a significant reduction in available information on these topics.
    Difference
    2%
    Check dated 2024-11-26T01:20:07.000Z thumbnail image
  5. Check
    119 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, with new resources added including links to MedlinePlus, PubMed articles, and clinical trial documents, while the previous version 2.12.1 has been removed.
    Difference
    2%
    Check dated 2024-11-18T11:25:39.000Z thumbnail image
  6. Check
    133 days ago
    Change Detected
    Summary
    The website has been updated from version v2.11.2 to v2.12.1.
    Difference
    0.1%
    Check dated 2024-11-04T08:40:12.000Z thumbnail image

Stay in the know with updates to Talazoparib in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.